PRNCR1 was reported to have high expression in aggressive prostate cancer and was reported to enhance both ligand-dependent and ligand-independent AR-mediated transcriptional activity by directly binding to the region of 549-623 amino acids of AR and therefore promotes prostate cancer growth [55]. Here, AR is linked to prostate cancer.